MedPath

The effect of estrogen and misoprostol on abortio

Not Applicable
Recruiting
Conditions
Abortion.
Early fetal death with retention of dead fetus
Registration Number
IRCT2017070934981N1
Lead Sponsor
Vice chancellor for research, Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Entry Criteria: Pregnant women aged 6 weeks to 14 weeks have two Missed Abortion ultrasounds.
Exit criteria: history of cesarean section, history of adrenal, kidney or liver disease, pulmonary disease, coagulation disorders, evidence of thromboembolic events, prostaglandin sensitivity, smoking, water repellent, vaginal bleeding, history of thromboembolism, estrogen dependent cancers Breast and genital system), intrauterine device, any normal amount of blood. Pre-treatment blood tests include CBC, liver and kidney function tests including blood urea, creatinine, albumin, globulin, liver enzymes, electrolytes, severe anemia, disorders Uncontrolled seizures

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Successful abortion. Timepoint: 4 hours after disposal of pregnancy. Method of measurement: Based on the amount of pregnancy residues in ultrasound after excretion of pregnancy products.
Secondary Outcome Measures
NameTimeMethod
Misoprostol side effects. Timepoint: Immediately after starting treatment. Method of measurement: Based on completed patient questionnaire.
© Copyright 2025. All Rights Reserved by MedPath